Shelagh M. Szabo
203 343 Railway St
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Estimating Utility Values Using the DMD-QoL: A Disease-Specific Preference-Based Measure for Duchenne Muscular Dystrophy (DMD).
Journal: Advances in therapy
Published: April 23, 2026
Controlling Symptoms versus Minimizing Negative Treatment Impact: A Grounded Theory Study of Heterogeneity in Patient Preferences for Psoriasis Treatments.
Journal: Patient preference and adherence
Published: February 19, 2026
"Are You Just Looking to 'Survive'?": A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer.
Journal: Cancers
Published: September 04, 2025
The Balancing Act of Paid Work and Caregiving in Duchenne Muscular Dystrophy (DMD): Results from a Cross-sectional Survey.
Journal: Advances in therapy
Published: September 02, 2025
Costs of obesity, obesity-related complications, and weight loss in the United States: A systematic literature review.
Journal: Journal of managed care & specialty pharmacy
Published: July 17, 2025
Preferences for Biologic Treatments: A Discrete Choice Experiment Survey of Canadians with Severe Asthma.
Journal: Patient preference and adherence
Published: January 16, 2025
Intelligence quotient scores among early-treated phenylketonuria patients: results from a systematic literature review.
Journal: Orphanet journal of rare diseases
Published: January 14, 2025
Morbidity and Mortality Risk Among People With HIV and Central or Visceral Adiposity: A Targeted Literature Review.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 18, 2024
Cost burden of cirrhosis and liver disease progression in metabolic dysfunction-associated steatohepatitis: A US cohort study.
Journal: Journal of managed care & specialty pharmacy
Published: June 07, 2024
Current Challenges of Using Patient-Level Claims and Electronic Health Record Data for the Longitudinal Evaluation of Duchenne Muscular Dystrophy Outcomes.
Journal: Advances in therapy
Published: February 15, 2024
Last Updated: 09/26/2026